tumor suppressor genes

Bladder cancer and p53: an example of what should not be done in biomarker research

M Tora MD PhD , M Kogevinas MD PhD , A Bustos MD , N Malats MD PhD , P Real MD PhD

mRNA expression of mdm2 in salivary gland neoplasms cell lines

A Mantesso PhD, SV Loducca PhD, I Bendit PhD, B Guaricochea PhD, VC Araujo PhD

Identification of new tumor suppressor genes based on in vivo functional inactivation of a candidate gene

OV Vorontsova PhD , J Li Msc , AI Protopopov PhD , RZ Gizatullin PhD , VI Kashuba PhD , ER Zabarovsky

P16 germline mutations and protein expression in melanoma lesions from familial melanoma patients

P Ghiorzo PhD , B Villaggio PhD , PL Santi MD , N Hayward PhD , G Bianchi-Scarra' PhD

A novel mechanism for c-Myc overexpression in tumors: c-Myc antagonizes p53-mediated transactivation

E Ceballos BS, MJ Muñoz PhD, JP Vaque BS, J Leon PhD

P53 expression as a prognostic determinant in resected distal bile duct carcinoma

AM Rijken MD , GJ Offerhaus MD , MM Polak PhD , DJ Gouma MD , TM van Gulik MD

Control of reck metastasis suppressor gene transcription

RM Sasahara PhD, SM Brochado BS, MC Sogayar PhD

The imprinted H19 gene as a putative tumor suppressor in squamous cell carcinoma of the head and neck

CA Rainho PhD , LP Kowalsk MD PhD , SR Rogatto PhD

Alterations of the FHIT gene in breast cancer: Association with tumour progression and patient survival

S Ingvarsson DSc, BI Sigbjornsdottir BSc, C Huiping MD, JG Jonasson MD, BA Agnarsson MD

Reduced expression of gelsolin gene and histone deacetylation in bladder cancer

K Haga MD , A Sazawa MD , H Fujita PhD , T Harabayashi MD PhD , N Shinohara MD PhD , M Takimot MD PhD , T Koyanagi MD PhD , N Kuzumaki MD PhD

Role of p53 positivity on the survival of patients with lung cancer as assessed by a systematic review of the literature

T Berghmans MD , E Steels MD , M Paesmans MSc , F Branle MD , A Burniat MD , L Ghisdal MD , JJ Lafitte MD , F Lemaitre MD , C Mascaux MD , AP Meert MD , F Vallot MD , JP Sculier MD

Expression of p53 and mdm2 mRNA and protein in colorectal carcinomas

AM Stark MD, M Duchrow PhD , R Broll MD PhD

Expression of p53 in epithelial ovarian carcinoma with regard to clinical and pathological parameters

P Traiman MD , PM Martins MD , JN Neto MD , G Uemura MD , EAP Nahas MD , CE Bacchi MD , AG Pontes MD , LA Luca MD

Similar UV responses are seen in a skin organ culture model as in human skin in vivo

H Bäckvall MSc , C Wassberg MD , F Pontén MD PhD , B Berne MD PhD

High prevalence of ANA (abundant in neuroepithelium area) genetic alteration in oral cancer

N Yamamoto DDS , K Uzawa DDS PhD , T Yakushiji DDS , T Shibahara DDS PhD , H Noma DDS PhD , H Tanzawa MD DDS PhD

Reduced levels of UV induced p53 and thymine dimers in human skin by topical photoprotection

C Wassberg MD , H Bäckvall MSc , F Pontén MD PhD , B Berne MD PhD

Myotonic dystrophy protein kinase induces the expression of ferritin heavy chain and interleukin1-a mRNAs in C2C12 myogenic culture

T Watanabe MD , N Sasagawa PhD , H Nakase MD , A Takagi MD , S Ishiura PhD , K Suzuki MD PhD

Altered expression of transcription factors in thymic lymphomas induced by X-rays in B6C3F1 mice

S Kakinuma PhD , M Nishimura , A Kubo , J Nagai , S Sasanuma , K Mita PhD , T Ogiu MD , H Majima DDS PhD , Y Katsura PhD , T Sado PhD , Y Shimada PhD

p53 expression in oral tongue carcinoma

VWH Chow MPhil , PW Yuen FRCS , KY Lam FRCPath , WK Ho FRCS , WI Wei FRCS

Tumor suppressor Smad4/DPC4 is implicated in angiogenesis, invasion and metastasis

I Schwarte-Waldhoff PhD , N Müller BS , S Klein-Scory PhD , O Volpert PhD , SA Hahn MD , NP Bouck PhD , W Schmiegel MD

Genetic alterations of p16/CDKN2 gene in human oral squamous cell carcinoma

T Yakushiji DDS , K Uzawa DDS PhD , N Yamamoto DDS , T Shibahara DDS PhD , H Noma DDS PhD , H Tanzawa MD DDS PhD

Abnormal FEZ1 gene expression in oral cancer

H Uesugi DDS, K Ono DDS, K Uzawa DDS PhD, H Tanzawa MD DDS PhD

p53 immunoreactivity of urothelial cells treated by Thinprep* and GenII* processors

E Piaton, E Galland, J Faÿnel

Mutational status of PTEN, protein tyrosine phosphatase gene, and the loci of putative tumor suppressor genes in 10q23 in human oral squamous cell carcinoma

A Miyakawa MD DDS PhD, Y Yamashita MD DDS PhD, T Watanabe DDS, K Uzawa DDS PhD, H Yokoe DDS PhD, H Tanzawa MD DDS PhD

FOXP1 a novel candidate tumour suppressor gene on chromosome 3p

AH Banham PhD, J Cordell HNC , M Jones Bsc , E Haralambieva MD , K Pulford PhD , C Fidler PhD , G Roncador Bsc , N Beasley BM FRCS , K Wood BM PhD , K Gatter BM PhD , DY Mason MD

Complementary roles for the p53 C-terminal and core domains in the recognition of DNA lesions

M Protopopova PhD, SB Zotchev PhD, G Selivanova PhD

Expression of p53 in lung preneoplastic and non-small cell lung cancer

B Martin PhD, JM Verdebout MD, C Mascaux MD, M Paesmans MSc, G Rouas, A Verhest MD, T Bosschaerts MD, V Ninane MD, JP Sculier MD

Regulation of Desmoglein 1 as a mean of alternative cancer therapy

D Baumann , A de Bruin PhD , MM Suter PhD , S Parisi PhD , E Müller PhD

p27kip1 and control of cell proliferation in medulloblastoma tumors and cell line

AM Adesina MD PhD, A Like BS

PTEN: A nuclear protein with cell cycle dependence

P Mitra PhD, Y Xue MSc, N Sultana MD, MB Lachyankar PhD, AH Ross PhD